Article

National Cancer Institute Support for Targeted Alpha-Emitter Therapy

2021-06-29

Abstract excerpt

<title>Abstract</title> <p>Radiopharmaceutical targeted therapy (RPT) has been studied for decades, however, recent clinical trials demonstrating efficacy has helped renew interest in the modality. Recognizing the potential, the National Cancer Institute (NCI) has co-organized workshops and organized interest groups on RPT and RPT dosimetry to encourage the community and facilitate rigorous preclinical and clinic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d5505edf-8c89-54eb-bf63-e7250710347a
DOI: 10.21203/rs.3.rs-650895/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

National Cancer Institute Support for Targeted Alpha-Emitter TherapyDOI 10.21203/rs.3.rs-650895/v1Read

Dosimetry-Driven Alpha Emitter Selection for Radioligand Therapy: Is daughter translocation a significant safety concern?Semantic proximity Read

Revisiting the Radiobiology of Targeted Alpha TherapySemantic proximity Read

Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsSemantic proximity Read

Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR AntibodySemantic proximity Read

18F-AlF-FAPI nanotracer visualized the quick response of sarcoma to radiotherapy by PET/CTSemantic proximity Read

Nuclear-based labeling of cellular immunotherapies: a simple protocol for preclinical useSemantic proximity Read

Extended single-dose toxicity study of [211At]meta-astatobenzylguanidine in normal mice in preparation for the first-in-human clinical trial of targeted alpha therapy for pheochromocytoma and paragangliomaSemantic proximity Read

[ <sup>18</sup> F]-Labeled PARP-1 PET Imaging of PSMA Targeted Alpha Particle Radiotherapy ResponseSemantic proximity Read

FLASH Radiotherapy: Mechanisms, Preclinical Evidence, and Clinical PotentialSemantic proximity Read

Reactivation of p53 as a radiosensitization strategy for mutant p53 cancers treated with high-LET radiotherapySemantic proximity Read

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to BedsideSemantic proximity Read

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)Semantic proximity Read